Cubist Systematic Strategies, LLC - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$185,467
-17.0%
65,076
+112.0%
0.00%0.0%
Q4 2022$223,511
-24.5%
30,702
-16.0%
0.00%
-50.0%
Q3 2022$296,000
-76.1%
36,541
-85.6%
0.00%
-75.0%
Q2 2022$1,240,000
+382.5%
253,054
+2224.4%
0.01%
+300.0%
Q1 2022$257,000
-41.7%
10,887
-56.3%
0.00%
-50.0%
Q4 2021$441,000
-48.7%
24,924
-18.3%
0.00%
-63.6%
Q3 2021$860,000
+2865.5%
30,498
+991.2%
0.01%
Q2 2021$29,000
-32.6%
2,795
-23.5%
0.00%
-100.0%
Q1 2021$43,000
+616.7%
3,655
+570.6%
0.00%
Q4 2020$6,000
+50.0%
545
+172.5%
0.00%
Q2 2020$4,0002000.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$10,403,6043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,718,881$25,391,8321.37%
COWEN AND COMPANY, LLC 4,308,359$19,129,1131.34%
RA Capital Management 11,609,704$51,547,0861.02%
RTW INVESTMENTS, LP 5,818,804$25,835,4900.54%
Acuitas Investments, LLC 134,811$598,5610.35%
Simplify Asset Management Inc. 570,519$2,533,1040.29%
Vivo Capital, LLC 520,000$2,308,8000.25%
BRANDYWINE MANAGERS, LLC 26,127$116,0040.20%
DENALI ADVISORS LLC 70,600$313,4640.11%
View complete list of FULCRUM THERAPEUTICS INC shareholders